ZURAZura Bio Limited
What is the market doing?
No clear lean: nothing decisive, though in a downtrend (−36% vs 200-day).
In a downtrend, below its 50- and 200-day averages. Price is −36% vs its 200-day average.
Heavily shorted, settled Sep 30, 2026, about a week of normal trading to cover.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How ZURA is trading
Zura Bio Limited is +0.90% over the past year while the S&P 500 is +16%: 15 points behind the market.
1-year return · S&P 500 +16%
- vs 200-day average
- −36%
vs 200-day average · a clear downtrend
- RSI (14)
- 39
RSI (14) · neutral
- Below its 52-week high
- 52%
Below its 52-week high
Details›
- Last close2026-10-23
- $3.36
- 1 monthS&P 500 −0.94%
- −19%
- 1 yearS&P 500 +16%
- +0.90%
- vs 50-day average$4.83
- −30%
- 52-week high
- $7.04
- 52-week low
- $3.36
- Annualised volatility
- 100%
| Year | Return |
|---|---|
| 2026 (year to date) | −36% |
| 2025 | +110% |
| 2024 | −46% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 3 | 1 of 3 | −18% |
| Feb | 3 | 2 of 3 | +6.0% |
| Mar | 3 | 0 of 3 | −15% |
| Apr | 4 | 2 of 4 | +4.1% |
| May | 4 | 1 of 4 | −11% |
| Jun | 4 | 3 of 4 | +13% |
| Jul | 4 | 2 of 4 | +5.5% |
| Aug | 4 | 3 of 4 | +13% |
| Sep | 4 | 1 of 4 | +20% |
| Oct | 4 | 1 of 4 | −13% |
| Nov | 3 | 1 of 3 | −9.2% |
| Dec | 3 | 1 of 3 | +4.9% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.